The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo
about
International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligandsLysophosphatidylinositol Signalling and Metabolic DiseasesPhospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizationsInternational Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂GPR55, a G-protein coupled receptor for lysophosphatidylinositol, plays a role in motor coordination.Δ(9)-Tetrahydrocannabinol treatment during human monocyte differentiation reduces macrophage susceptibility to HIV-1 infectionMinireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.Inflammatory and Neuropathic Nociception is Preserved in GPR55 Knockout Mice.Pharmacological characterization of GPR55, a putative cannabinoid receptorIdentification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands.Lysophosphatidylinositol causes neurite retraction via GPR55, G13 and RhoA in PC12 cells.Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling.GPR55 ligands promote receptor coupling to multiple signalling pathways.A role for L-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells.The atypical cannabinoid O-1602 stimulates food intake and adiposity in rats.Novel lysophosphoplipid receptors: their structure and function.GPR55 deletion in mice leads to age-related ventricular dysfunction and impaired adrenoceptor-mediated inotropic responses.Medical use of cannabis. Cannabidiol: a new light for schizophrenia?The promise and dilemma of cannabinoid therapy: lessons from animal studies of bone disease.Cannabinoid receptors as target for treatment of osteoporosis: a tale of two therapies.Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists.Noncanonical G-protein-dependent modulation of osteoclast differentiation and bone resorption mediated by Pasteurella multocida toxinGenetic background can result in a marked or minimal effect of gene knockout (GPR55 and CB2 receptor) in experimental autoimmune encephalomyelitis models of multiple sclerosis.Identification of the GPR55 antagonist binding site using a novel set of high-potency GPR55 selective ligands.GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils.Skeletal lipidomics: regulation of bone metabolism by fatty acid amide family.The therapeutic potential of orphan GPCRs, GPR35 and GPR55.Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages.Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids.The L-α-lysophosphatidylinositol/GPR55 system and its potential role in human obesity.The Effects of the Endocannabinoids Anandamide and 2-Arachidonoylglycerol on Human Osteoblast Proliferation and DifferentiationA synergistic interaction of 17-β-estradiol with specific cannabinoid receptor type 2 antagonist/inverse agonist on proliferation activity in primary human osteoblasts.A role for GPR55 in human placental venous endothelial cells.Pharmacological profiling of the hemodynamic effects of cannabinoid ligands: a combined in vitro and in vivo approachThe GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis.Molecular Targets of Cannabidiol in Neurological DisordersCannabinoids and bone: endocannabinoids modulate human osteoclast function in vitroDeletion of Gpr55 Results in Subtle Effects on Energy Metabolism, Motor Activity and Thermal Pain SensationRole of cannabinoids in the regulation of bone remodeling
P2860
Q24605072-50CC9B4D-A290-46DA-BC60-A949A5025BD8Q26771102-A63CC695-991D-44C6-9D08-6CDEA69DF0C4Q28286551-4EB19E27-D164-4461-8710-D60EECDB0F48Q28298445-5CAA0F04-ED8B-42D2-8699-10B58C5B9378Q28508581-32B0C4EA-F531-4186-828D-B4C19278ACE5Q33605261-9C3317C5-6391-4C8B-B5BC-F6881F9C1A4AQ33636763-40C68909-1DB1-4A30-A560-2D098BA28B33Q33681317-2EBD130C-4D88-44B7-881A-64C0F4B5804BQ33869340-CC6F684D-41CA-4BBE-9D32-217DA030F4D8Q33887246-FCB8FCCF-A268-44CA-A8DC-FE10699629B6Q34014550-EABBAE7E-283E-4ED6-AAAD-291440D4E599Q34070354-903CA4FF-81C4-49D7-9D67-162796F99D36Q34098246-37FB448D-1303-4019-ABAB-08AD6C423F81Q34098297-BE52E86B-5373-4E17-9D49-183F2BCC686DQ34222264-E39856BE-AF33-4328-BED7-59D975E137ADQ34238610-FAB420D6-2180-4802-A1BC-345DCB86C54AQ34282113-77CA46CF-ECFF-4905-8DF2-C44D257F3D62Q34308885-853FF04B-37E5-4DC6-9BD2-90116AA01B1AQ34393890-48DA8CF9-BA4C-484D-8AE3-CB7A689665CBQ34402180-E30A1844-5C65-4FD2-8EFF-FD6E8D9F01F1Q34453695-08BAABB5-3983-4ED3-B6F0-F6598BE45582Q34530518-7145A41C-3BB7-4A24-9CE1-1CF84E3D0450Q35018622-96D219D9-5A0A-4DB7-B1E7-AA70663F808FQ35052556-19111EFF-3904-4050-81AB-F0EEEE8265A0Q35094180-DF8AC03D-1EA9-4383-A65A-1C3F21375746Q35193296-213C82CD-E473-42F7-91B0-F6FD260E52BAQ35425244-C022944D-D36A-4BEC-AF4A-A492A9B7681FQ35532072-7BD8646A-4138-40AF-BCDC-AA9B38248A07Q35602343-E71EBD7F-7919-4486-A921-1D5B517ABE4EQ35643909-70596CB7-D0C9-475D-9CCC-CBE517A85C60Q35696499-161E4495-8604-4E15-8CB6-5829092BD1F9Q35790543-07EE320B-5AA3-4E8D-9BBD-B8509E3181BCQ35803402-B692D031-8A5B-4FD5-9E5C-9B92B0AD6591Q35806135-326BA087-DA9F-4169-8905-77D3A8113FF3Q35822367-5711CA6A-8A7E-44B0-9A0C-F8F902725E62Q35978114-E363D98D-2DEA-42A9-9B61-C0DBFA7B61BDQ36157649-DFE6DA39-B8FF-4B40-B5CB-8B004988B8ADQ36176547-579716D4-568F-42A5-822E-0D173A91C299Q36219994-D5C99884-3818-4A87-8828-9972D66976A1Q36404379-0F8C7D16-CB6D-43FB-9AE0-5C46953DB91B
P2860
The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The putative cannabinoid recep ...... in vitro and bone mass in vivo
@ast
The putative cannabinoid recep ...... in vitro and bone mass in vivo
@en
The putative cannabinoid recep ...... in vitro and bone mass in vivo
@en-gb
The putative cannabinoid recep ...... in vitro and bone mass in vivo
@nl
type
label
The putative cannabinoid recep ...... in vitro and bone mass in vivo
@ast
The putative cannabinoid recep ...... in vitro and bone mass in vivo
@en
The putative cannabinoid recep ...... in vitro and bone mass in vivo
@en-gb
The putative cannabinoid recep ...... in vitro and bone mass in vivo
@nl
prefLabel
The putative cannabinoid recep ...... in vitro and bone mass in vivo
@ast
The putative cannabinoid recep ...... in vitro and bone mass in vivo
@en
The putative cannabinoid recep ...... in vitro and bone mass in vivo
@en-gb
The putative cannabinoid recep ...... in vitro and bone mass in vivo
@nl
P2093
P2860
P921
P3181
P356
P1476
The putative cannabinoid recep ...... in vitro and bone mass in vivo
@en
P2093
Erik Ryberg
Lauren S Whyte
Natalie A Sims
Peter J Greasley
Ruth A Ross
Susan A Ridge
P2860
P304
P3181
P356
10.1073/PNAS.0902743106
P407
P577
2009-09-22T00:00:00Z